The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Frame this as a valuation test for Coherent after a major rally and up to $50 million of CHIPS Act funding for its Indium Phosphide semiconductor facility.
According to Simply Wall Street, its analysis suggests the market price may be about 77% above estimated fair value. Connect federal funding to execution risk and possible AI-spending slowdown instead of unsupported peer/Bloomberg comparisons.
Sign in to access this content
Sign InKeep COHR as the only instrument and add EL7’s earlier CHIPS-funding story to also-see because it is the closest direct context.